This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Subacute or Chronic Pain Pain: a Randomized Controlled Trial | MicrobiomeTrials
← Back to trials NCT06350786
Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Subacute or Chronic Pain Pain: a Randomized Controlled Trial Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-06-12Est. Completion: 2026-09-30
Enrollment target: 86 participantsLocations University Hospital Zurich, Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, Zurich, Canton of Zurich, Switzerland Other microbiome trials you might be interested in Procedural Pain Acute Pain Needle-Related Pain and Distress Fear Anxiety Phlebotomy
What is this study about, in short?
This study looks at simple, no-cost ways to reduce the pain and fear that children …
Multiple Locations Est. completion May 2027
Video-assisted Thoracoscopic Surgery (VATS) Wedge Resection Segmentectomy Lobectomy of the Lungs Incisional Infiltration
Triamcinolone
Video-assisted thoracoscopic surgery (VATS) is less invasive compared to traditional thoracotomy, but it is still report…
Beijing, China Est. completion May 31, 2027
Trauma Injury Depression Anxiety Anger Pain
Animal assisted therapy (AAT) with dogs has been shown to be beneficial for a wide range of patients with both acute and…
Boston, United States Est. completion Dec 2026